Results 201 to 210 of about 1,108,559 (366)
Tumor B‐cell infiltration in platinum‐treated advanced muscle‐invasive urothelial carcinoma
Molecular Oncology, EarlyView.Bladder tumors with higher pretreatment memory B‐cell infiltration were linked to longer survival after cisplatin chemotherapy, but not carboplatin. These tumors also showed more organized immune structures (tertiary lymphoid structures) and a shared pro‐inflammatory B‐cell‐rich community, suggesting that memory B cells may help identify patients most ...
Konrad Stawiski +10 more
wiley +1 more source
Hamartoma gástrico: dos casos tratados con resección local
Cirugía del Uruguay, 1977 Los autores runalizan 2 observaciones clínicas de hamartoma gástrico, diagnosticadas en el acto operatorio y tratadas con resección simple de la masa tumoral.
Jorge W Baldizán +3 more
doaj
Molecular Oncology, EarlyView.Patient‐derived organoids (PDOs) from pancreatic, colorectal, and gastric cancers were used to evaluate standard and experimental therapies. Incorporating cancer‐associated fibroblasts (CAFs) into organoid cultures improved patient therapy outcome prediction.
Marcin Grochowski +12 more
wiley +1 more source
Direct relationship between radiobiological hypoxia in tumors and monoclonal antibody detection of EF5 cellular adducts [PDF]
, 1996 Jung‐Eun Lee +3 more
openalex +1 more source
Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer
Molecular Oncology, EarlyView.Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola +11 more
wiley +1 more source
Testicular Non-Seminomatous Germ Cell Tumor [PDF]
, 2020 National Cancer Institute
openalex +1 more source
Molecular Oncology, EarlyView.Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim +3 more
wiley +1 more source
Review for "Changes of stem cell niche during experimental pituitary tumor development"
, 2021 openalex +1 more source
Jejunum and Ileum Neuroendocrine Tumor Pathologic Primary Tumor TNM Finding v8 [PDF]
, 2020 National Cancer Institute
openalex +1 more source